CD34 and myeloproliferative neoplasm: To investigate if the phenotypically defined (CD34+CD45dimCD38−) NSC in MPN patients express PD‐L1 on their cell surface, we analyzed cells isolated from fresh BM samples of 49 MPN patients and 7 healthy controls by flow cytometry (Figures 3A,B and S4).